Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023
by from Morbidity and Mortality Weekly Report (MMWR) on (#67RP1)
This report describes similar early safety findings from the Vaccine Adverse Event Reporting System for bivalent booster vaccination in children aged 5-11 years as the monovalent booster vaccination.